These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 299730)

  • 21. Letter: Relief of action myoclonus by 5-hydroxytryptophan.
    Chadwick D; Reynolds EH; Marsden CD
    Lancet; 1974 Jul; 2(7872):111-2. PubMed ID: 4136988
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 23. Action myoclonus following acute cerebral anoxia.
    DeLisa JA; Stolov WC; Troupin AS
    Arch Phys Med Rehabil; 1979 Jan; 60(1):32-6. PubMed ID: 420569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
    Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B
    Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].
    Erro ME; Navarro MC
    Rev Neurol; 2009 Jan; 48 Suppl 1():S1-6. PubMed ID: 19222008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disorders.
    Pranzatelli MR
    Med Hypotheses; 1989 Sep; 30(1):55-60. PubMed ID: 2571916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 30. From the NIH: New treatment for myoclonus patients.
    JAMA; 1980 May; 243(17):1705-6. PubMed ID: 6965990
    [No Abstract]   [Full Text] [Related]  

  • 31. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity.
    Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y
    Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of intentional myoclonus in hypoxic encephalopathy, successfully treated with clonazepam].
    Grechuta M; Szczechowski L; Dawidowicz-Sobczak K; Grzybowski G; Strzyzewska L
    Wiad Lek; 1986 Jun; 39(11):781-3. PubMed ID: 3776196
    [No Abstract]   [Full Text] [Related]  

  • 33. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 34. Action myoclonus (Lance-Adam syndrome) secondary to strangulation with dramatic response to alcohol.
    Jain S; Jain M
    Mov Disord; 1991; 6(2):183. PubMed ID: 2057013
    [No Abstract]   [Full Text] [Related]  

  • 35. Action myoclonus and serotoninergic activity.
    De Lèan J
    N Engl J Med; 1977 Jun; 296(24):1414-5. PubMed ID: 859554
    [No Abstract]   [Full Text] [Related]  

  • 36. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 37. The pharmacology of myoclonus.
    Pranzatelli MR; Snodgrass SR
    Clin Neuropharmacol; 1985; 8(2):99-130. PubMed ID: 2988772
    [No Abstract]   [Full Text] [Related]  

  • 38. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
    Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J
    Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation.
    Muslu B; Kilci O; Horasanli E; Dikmen B
    Clin Neuropharmacol; 2009; 32(4):236. PubMed ID: 19644236
    [No Abstract]   [Full Text] [Related]  

  • 40. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.